TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis

NCT06733519 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Primary Biliary Cholangitis

Interventions

DRUG: Nalmefene
DRUG: Placebo

Sponsor

Tharimmune Inc